Advice to Patients
- Provide patient with a copy of manufacturer’s patient information.
- Potential risk of complex sleep-related behaviors; importance of immediately informing clinician if sleep-driving events or other complex behaviors occur.
- Importance of advising patients to immediately discontinue drug and inform clinician if signs of an allergic reaction (e.g., rash, hives, dyspnea, swelling of tongue or throat) occur.
- Importance of administering immediately before retiring.
- Importance of taking only when able to get a full night’s sleep (i.e., 7–8 hours) before being active again.
- Importance of taking only as prescribed; do not increase dosage or duration of therapy unless otherwise instructed by a clinician.
- Importance of not abruptly discontinuing therapy if drug has been used for more than 1–2 weeks; consult clinician about discontinuing use.
- Potential for drug to impair mental alertness or physical coordination; use caution when operating machinery or performing hazardous tasks until effects on individual are known.
- Importance of informing clinicians of existing or contemplated concomitant therapy, including prescriptions and OTC drugs, and of concomitant illnesses, particularly depression.
- Importance of avoiding alcohol-containing beverages or products.
- Importance of informing clinicians of any behavioral or mental changes, memory impairment, tolerance, or dependence/withdrawal symptoms.
- Risk of rebound insomnia for 1 or 2 nights after discontinuance.
- Importance of women informing their clinician if they are or plan to become pregnant or plan to breast-feed.
- Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Subject to control under the Federal Controlled Substances Act of 1970 as a schedule IV (C-IV) drug.
Zolpidem Tartrate
| Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|
| Oral | Tablets, extended-release, film-coated | 6.25 mg | Ambien CR® ( C-IV) | Sanofi-Aventis |
| | 12.5 mg | Ambien CR® ( C-IV) | Sanofi-Aventis |
| Tablets, film-coated | 5 mg | Ambien® ( C-IV) | Searle |
| | 10 mg | Ambien® ( C-IV) | Searle |
Comparative Pricing
Pricing information provided by drugstore.com.
| Ambien 10MG TABS | SANOFI PHARMACEUTICALS | 30/$134.12 or 90/$391.02 |
| Ambien 5MG TABS | SANOFI PHARMACEUTICALS | 30/$134.12 or 90/$391.02 |
| Ambien CR 12.5MG TBCR | SANOFI PHARMACEUTICALS | 30/$110.99 or 90/$319.97 |
| Ambien CR 6.25MG TBCR | SANOFI PHARMACEUTICALS | 30/$109.99 or 90/$294.97 |
AHFS Drug Information. © Copyright, 1959-2007, Selected Revisions September 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
Remember, keep this and all other medicines out of the reach of children,
never share your medicines with others, and use this medication only for the indication prescribed.
Print
Email
Media Gallery
Drug Info Tools
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
